COMMUNIQUÉS West-GlobeNewswire

U.S. Food and Drug Administration Approves SIGA Technologies’ TPOXX® (tecovirimat) for the Treatment of Smallpox

13/07/2018 - 21:47

- First therapy specifically approved for smallpox advances health security against a significant bioterror threat- - Company Granted Priority Review Voucher - NEW YORK, July 13, 2018 (GLOBE NEWSWIRE) -- SIGA [...]

CyberFuels Inc. Announces New Sales, Marketing and Research Office in Dearborn, MI.

13/07/2018 - 19:55

PALM BEACH GARDENS, Fla., July 13, 2018 (GLOBE NEWSWIRE) -- EncounterCare solutions (OTC:ECSL) is pleased to announce that its wholly owned subsidiary CyberFuels Inc. is opening a new Research, Sales and Marketing [...]

Clementia nomme Steve Forte, un cadre financier expérimenté, au poste de chef de la direction financière

13/07/2018 - 19:11

MONTRÉAL, 13 juill. 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ:CMTA), société biopharmaceutique au stade clinique proposant des traitements novateurs pour les personnes atteintes de troubles osseux [...]

Peter Granick Joins Analogic as Vice President, Operations

13/07/2018 - 18:00

PEABODY, Mass., July 13, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation, a leading provider of advanced imaging technologies to the medical imaging and security industries, today announced and welcomed the addition of Mr [...]

LifePoint Health To Broadcast Its Second Quarter 2018 Conference Call Live On The Internet

13/07/2018 - 17:00

Brentwood, Tenn., July 13, 2018 (GLOBE NEWSWIRE) -- LifePoint Health, Inc. (NASDAQ: LPNT) announced today that it will provide an online Web simulcast of its second quarter 2018 conference call on Friday, July 27, 2018 [...]

CFN Media Exclusive Interview: Segra International's Cannabis Micropropagation Revolution

13/07/2018 - 16:26

SEATTLE, WA, July 13, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an exclusive [...]

Sienna Announces July Dividend

13/07/2018 - 16:00

MARKHAM, Ontario, July 13, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX:SIA) today announced a dividend of $0.075 per common share of the Company (each, a “Common Share”) for [...]

Rafael Pharmaceuticals Appoints Two Prominent Gastrointestinal Oncologists from Europe to its Medical Advisory Board to Support Global Development of CPI-613 in Pancreatic Cancer and Other Gastrointestinal Malignancies

13/07/2018 - 15:15

Newark, NJ, July 13, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced the appointment of Eric Van Cutsem MD, PhD and Josep [...]

Capricor Therapeutics and PPMD to Host Webinar for Duchenne Muscular Dystrophy Community on July 18

13/07/2018 - 15:00

Opportunity to Learn More about Company’s HOPE-2 Clinical Trial and CAP-1002 Investigational Therapy for Duchenne Muscular Dystrophy LOS ANGELES, July 13, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR) and [...]

Exclusive CFN Media Interview: RISE Life Science Study on Cannabis and Sexual Health (Part 2)

13/07/2018 - 15:00

SEATTLE, July 13, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an exclusive interview [...]

Michael Auer, PT, DPT, C/NDT, is Selected to the American Health Council’s Physical Therapy Board

13/07/2018 - 14:00

NEW YORK, July 13, 2018 (GLOBE NEWSWIRE) -- The American Health Council selected Michael Auer, PT, DPT, C/NDT to its Physical Therapy Board. Currently a Doctor of Physical Therapy and Director of Rehabilitation Therapy [...]

Clementia Appoints Experienced Financial Executive Steve Forte as Chief Financial Officer

13/07/2018 - 12:30

MONTREAL, July 13, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ:CMTA), a clinical-stage biopharmaceutical company innovating new treatments for people with ultra-rare bone disorders and other diseases [...]

RavenQuest Completes Oversubscribed Private Placement

13/07/2018 - 12:00

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, July [...]

RAMSAY GENERALE DE SANTE : OPA CAPIO

13/07/2018 - 08:35

PRESS RELEASE THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, OR SOUTH AFRIC A. THE OFFER IS NOT BEING MADE TO (AND [...]

RAMSAY GENERALE DE SANTE : OPA CAPIO

13/07/2018 - 08:35

COMMUNIQUÉ DE PRESSE LE PRESENT COMMUNIQUE DE PRESSE NE PEUT ETRE, DIRECTEMENT OU INDIRECTEMENT, DISTRIBUE OU PUBLIE EN AUSTRALIE, CANADA, HONG KONG, JAPON, NOUVELLE ZELANDE, OU AFRIQUE DU SUD. L'OFFRE N'EST PAS FAITE [...]

DBV Technologies: Half-Year Report on the DBV Technologies Liquidity Contract and Transfer to Oddo BHF

13/07/2018 - 07:31

AMF REGULATED INFORMATION Montrouge, France, July 13, 2018 Half-Year Report on the DBV Technologies Liquidity Contract and Transfer to Oddo BHF DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market [...]

DBV Technologies : Bilan semestriel du contrat de liquidité DBV Technologies et transfert du contrat à Oddo BHF

13/07/2018 - 07:31

Informations Réglementées Montrouge, France, le 13 juillet (7h30 CEST), 2018 Bilan semestriel du contrat de liquidité DBV Technologies et transfert du contrat à Oddo BHF DBV Technologies (Euronext : DBV - ISIN : [...]

ObsEva SA to start trading today on the SIX Swiss Exchange

13/07/2018 - 07:30

Trading of ObsEva's shares on SIX Swiss Exchange starts under the ticker symbol 'OBSN' Reference price at CHF 15.00 per share ObsEva with unique pipeline of novel and potential best-in class therapeutics to address [...]

Spero Therapeutics Announces Pricing of Securities Offering

13/07/2018 - 02:10

CAMBRIDGE, Mass., July 12, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments [...]